Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
1.86
0.24 (14.81%)
At close: Aug 15, 2025, 3:59 PM
1.89
1.61%
After-hours: Aug 15, 2025, 07:53 PM EDT
Inovio Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 182.34K | 283.1K | 217.76K | 203.41K | 591.86K | 717.07K | 832.01K | 854.03K | 9.62M | 10.18M | 10.26M | 10.98M | 2.11M | 1.6M | 1.77M | 6.52M | 6.46M | 6.46M |
Cost of Revenue | 1.54M | 2.37M | 3.13M | 2.53M | 2.8M | 3.11M | 32.53M | 33.7M | 34.03M | 34.3M | 60.1M | 60.13M | 105.86M | 175.25M | 158.32M | 183.24M | 162.61M | 114.18M |
Gross Profit | -1.36M | -2.09M | -2.91M | -2.33M | -2.2M | -2.39M | -31.7M | -32.85M | -24.41M | -24.12M | -49.84M | -49.15M | -103.74M | -173.65M | -156.55M | -176.73M | -156.15M | -107.72M |
Operating Income | -23.16B | -105.96M | -112.4M | -119.42M | -117.12M | -120.96M | -133.43M | -161.98M | -172.7M | -239.79M | -267.57M | -317.14M | -341.33M | -320.4M | -301.22M | -225.05M | -201.43M | -151.4M |
Interest Income | 613.41M | 4.07M | 4.77M | 5.73M | 6.57M | 7.43M | 8.13M | 8.2M | 7.63M | 6.32M | 4.78M | 3.79M | 3.19M | 3.26M | 3.36M | 3.39M | 3.53M | 3.66M |
Pretax Income | -48.72B | -25.24B | -25.25B | -25.25B | -121.64M | -124.94M | -135.12M | -164.58M | -168.43M | -241.39M | -277.65M | -330.14M | -352.52M | -326.17M | -303.22M | -218.69M | -137.59M | -183.72M |
Net Income | -68.4B | -44.91B | -25.25B | -25.25B | -121.64M | -124.94M | 2.85B | 2.83B | 2.82B | 2.74B | -287.66M | -342.94M | -363.5M | -333.17M | -303.66M | -221.05M | -141.71M | -188.27M |
Selling & General & Admin | 17.6B | 9.05B | 34.63M | 37.87M | 39.18M | 43.33M | 47.41M | 51.29M | 53.19M | 88.12M | 90.19M | 90.28M | 91.62M | 55.82M | 53.75M | 48.32M | 45.28M | 43.68M |
Research & Development | 30.64B | 16.15B | 75.62M | 79.99M | 76.76M | 77.41M | 86.68M | 111.54M | 129.13M | 161.85M | 187.65M | 237.83M | 251.83M | 266.17M | 249.24M | 183.24M | 162.61M | 114.18M |
Other Expenses | -25.09B | -25.09B | n/a | n/a | -1.03M | -2.46M | -4.89M | -7.65M | -7.56M | -6.13M | -3.86M | -919.7K | -7.4K | 180.93K | 343.37K | 175.12K | 66.97K | 3.85M |
Operating Expenses | 23.16B | 104.64M | 110.25M | 117.86M | 114.91M | 119.71M | 133.05M | 161.8M | 182.32M | 249.97M | 277.84M | 328.11M | 343.45M | 322M | 302.99M | 231.57M | 207.89M | 157.86M |
Interest Expense | n/a | n/a | 177.83K | 460.16K | 773.65K | 1.09M | 1.22M | 1.25M | 1.25M | 1.25M | 1.25M | 1.42M | 1.58M | 1.74M | 1.94M | 2.52M | 4.03M | 6.41M |
Selling & Marketing Expenses | -8.61B | -18.8B | -18.8B | -18.8B | -10.2B | -175.23K | -175.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 31.98M | 65.27M | 71.64M | 119.63M | 117.71M | 121.68M | 134.26M | 162.83M | 182.32M | 249.97M | 277.84M | 328.11M | 343.45M | 322M | 302.99M | 231.57M | 207.89M | 157.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -2.99B | -2.99B | -2.99B | -2.99B | 10.01M | 12.81M | 11.43M | 7.32M | 1.6M | -3.22M | -33.45M | 60.52M |
Shares Outstanding (Basic) | 38.83M | 27.16M | 27.16M | 28.14M | 27.2M | 23.29M | 22.79M | 22.39M | 22.03M | 21.54M | 21.39M | 249.35M | 235.28M | 218.94M | 210.3M | 210.3M | 209.56M | 202.41M |
Shares Outstanding (Diluted) | 38.83M | 27.16M | 27.16M | 28.14M | 27.2M | 23.29M | 22.79M | 22.39M | 22.03M | 21.54M | 21.39M | 249.35M | 235.28M | 218.94M | 210.3M | 210.3M | 209.56M | 202.41M |
EPS (Basic) | -896.1 | -896.68 | -897.48 | -897.88 | -5.12 | -5.54 | 132.69 | 131.37 | 132.73 | 133.86 | -3.44 | -1.53 | -1.66 | -1.57 | -1.46 | -1.1 | -0.69 | -1.13 |
EPS (Diluted) | -1.62K | -1.62K | -897.48 | -897.88 | -5.12 | -5.54 | 132.69 | 131.37 | 132.73 | 133.86 | -3.44 | -1.53 | -1.66 | -1.57 | -1.46 | -1.1 | -0.7 | -1.14 |
EBITDA | -48.18B | -25.12B | -103.95M | -109.89M | -118.07M | -120.74M | -130.39M | -158.65M | -162.17M | -234.87M | -270.9M | -323.19M | -345.62M | -319.4M | -296.56M | -211.7M | -129.39M | -173.08M |
EBIT | -64.24M | -96.48M | -107.08M | -112.42M | -120.87M | -123.85M | -133.89M | -163.32M | -167.18M | -240.14M | -276.4M | -328.72M | -350.94M | -324.43M | -301.29M | -216.17M | -133.56M | -177.31M |
Depreciation & Amortization | 2.29M | 3.11M | 3.13M | 2.53M | 2.8M | 3.11M | 3.5M | 4.68M | 5.01M | 5.27M | 5.5M | 5.53M | 5.32M | 5.03M | 4.73M | 5.25M | 4.94M | 4.49M |